ONCO-FETAL REPROGRAMMING DRIVES HIGH-RISK JUVENILE MYELOMONOCYTIC LEUKEMIA, WHICH CAN BE TARGETED BY ANTI-CD52 TREATMENT
Titel:
ONCO-FETAL REPROGRAMMING DRIVES HIGH-RISK JUVENILE MYELOMONOCYTIC LEUKEMIA, WHICH CAN BE TARGETED BY ANTI-CD52 TREATMENT
Auteur:
Hartmann, Mark Schönung, Maximilian Rajak, Jovana Hey, Joschka Maurer, Valentin Hai, Ling Staeble, Sina Langstein, Jens Bauer, Katharina Hakobyan, Mariam Jardine, Laura Bohler, Sheila Vonficht, Dominik Maag, Abdul-Habib Lebrecht, Dirk Bernt, Katrin M. Roelz, Roland Boch, Tobias Khabirova, Eleonora Lutsik, Pavlo Haas, Simon Haniffa, Muzlifah Behjati, Sam Mallm, Jan-Philipp Buske, Christian Milsom, Michael D. Fröhling, Stefan Bonder, Marc-Jan Niemeyer, Charlotte Flotho, Christian Plass, Christoph Erlacher, Miriam Schlesner, Matthias Lipka, Daniel B.